Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 128 of 1,261
  1. US 11939379

    Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies

    The Regents of the University of California Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  2. US 11939317

    Amide compounds and method for making and using

    Rigel Pharmaceuticals, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  3. US 11939327

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  4. US 11939343

    Sting agonist compounds and methods of use

    Mersana Therapeutics, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  5. US 11938227

    Lipid nanoparticles encapsulation of large RNA

    ARCTURUS THERAPEUTICS, INC. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  6. US 11939301

    5HT1F receptor agonists and mitochondrial biogenesis

    United States Government as represented by the Department of Veterans Affairs Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  7. US 11938221

    Multivalent nanoparticle-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  8. US 11939346

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  9. US 11939402

    Antifungal peptides, compounds including the same, and methods of use thereof

    Seton Hall University Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  10. US 11938174

    Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders

    Takeda Pharmaceutical Company Limited Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  11. US 11938177

    Peptide vaccine formulations and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  12. US 11938124

    Combination therapy for treatment of cancer

    PMV PHARMACEUTICALS, INC. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  13. US 11938171

    Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods

    THE BIOREGENTECH INSTITUTE, INC. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  14. US 11938182

    Halogenated xanthenes as vaccine adjuvants

    Provectus Pharmatech, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  15. US 11938134

    Metalloenzyme inhibitor compounds

    Eikonizo Therapeutics, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  16. US 11938149

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  17. US 11938233

    1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof

    UNIVERSITΓ„TSKLINIKUM REGENSBURG Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  18. US 11939297

    Cannabinoid receptor mediating compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  19. US 11939345

    Physiologically stable fluorophore and performing fluorescence probing

    Government of the United States of America, as represented by the Secretary of Commerce Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  20. US 11939356

    Self-assembling insect ferritin nanoparticles

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  21. US 11932624

    MDM2 degraders and uses thereof

    Kymera Therapeutics, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  22. US 11932870

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Fate Therapeutics, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  23. US 11932703

    Anti-ROR1 antibody and ROR1-targeting engineered cells

    Caribou Biosciences, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  24. US 11932633

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.